Interleukin 6-blockade treatment for severe COVID-19 in two patients with multiple myeloma

Br J Haematol. 2020 Jul;190(1):e9-e11. doi: 10.1111/bjh.16787. Epub 2020 May 18.
No abstract available

Keywords: COVID-19; cytokine release syndrome; interleukin-6; myeloma; tocilizumab.

Publication types

  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Betacoronavirus*
  • COVID-19
  • Coronavirus Infections / drug therapy*
  • Humans
  • Interleukin-6 / antagonists & inhibitors*
  • Male
  • Middle Aged
  • Multiple Myeloma* / drug therapy
  • Multiple Myeloma* / virology
  • Neoplasm Proteins / administration & dosage*
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • SARS-CoV-2
  • Severity of Illness Index

Substances

  • Antibodies, Monoclonal, Humanized
  • IL6 protein, human
  • Interleukin-6
  • Neoplasm Proteins
  • tocilizumab